Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elisabeth Dibando Obie"'
Autor:
Relindis Ekanya, Elisabeth Dibando Obie, Louise Hamill, Sophie Thorogood, Raphael Awah Abong, Abdel Jelil Njouendou, Andrew Amuam, Bertrand Lontum Ndzeshang, Desmond Akumtoh Nkimbeng, Jerome Fru Cho, Mathias Eyong Esum, Peter Enyong, Joseph D. Turner, Mark J. Taylor, Samuel Wanji
Publikováno v:
Parasites & Vectors, Vol 15, Iss 1, Pp 1-11 (2022)
Abstract Background Onchocerciasis control using ivermectin alone has been achieved in some endemic savannah zones of Africa. In the forest regions, the co-endemicity with Loa loa has led to severe adverse events (SAEs) resulting in poor adherence of
Externí odkaz:
https://doaj.org/article/b70ab87925aa432285e5b20aead38544
Autor:
Samuel Wanji, Theobald Mue Nji, Louise Hamill, Laura Dean, Kim Ozano, Abdel J. Njouendou, Raphael A. Abong, Elisabeth Dibando Obie, Andrew Amuam, Relindis Ekanya, Winston Patrick Chounna Ndongmo, Bertrand L. Ndzeshang, Ebua Gallus Fung, Dum-Buo Nnamdi, Desmond Akumtoh Nkimbeng, Samuel Teghen, Emmanuel Kah, Helen Piotrowski, Armelle Forrer, Jahangir A. M. Khan, Maame E. Woode, Louis Niessen, Victoria Watson, Zakariaou Njoumemi, Michele E. Murdoch, Rachael Thomson, Sally Theobald, Peter Enyong, Joseph D. Turner, Mark J. Taylor
Publikováno v:
Parasites & Vectors, Vol 12, Iss 1, Pp 1-13 (2019)
Abstract Background Onchocerciasis is a priority neglected tropical disease targeted for elimination by 2025. The standard strategy to combat onchocerciasis is annual Community-Directed Treatment with ivermectin (CDTi). Yet, high prevalence rates and
Externí odkaz:
https://doaj.org/article/461a69575fce44e5b20bcada9f192621
Autor:
Laura Dean, Rachael Thomson, Kim Ozano, Sally Theobald, Armelle Forrer, Samuel Wanji, Elisabeth Dibando Obie, Theobald Mue Nji, Louise Hamill, Helen Piotrowski, Abdel J Njouendou, Relindis Ekanya, Winston Patrick Chounna Ndongmo, Ebua Gallus Fung, Dum-Buo Nnamdi, Raphael A Abong, Amuam Andrew Beng, Mathias Esum Eyong, Bertrand L Ndzeshang, Desmond Akumtoh Nkimbeng, Samuel Teghen, Anicetus Suireng, Ernerstine Ebot Ashu, Emmanuel Kah, Michele M Murdoch, Peter Enyong, Joseph D Turner, Mark J Taylor
Publikováno v:
BMJ Global Health, Vol 6, Iss 1 (2021)
Introduction Onchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to
Externí odkaz:
https://doaj.org/article/11c2b86a7c264a7cb75b5b5f24429409
Autor:
Armelle Forrer, Samuel Teghen, Sally Theobald, Raphael A. Abong, Dum-Buo Nnamdi, Bertrand L. Ndzeshang, Elisabeth Dibando Obie, Desmond Akumtoh Nkimbeng, Michele E. Murdoch, Esum Mathias Eyong, Helen Piotrowski, Samuel Wanji, Relindis Ekanya, Rachael Thomson, Ebua Gallus Fung, Kim Ozano, Patrick W. Chounna Ndongmo, Andrew Amuam, Peter Enyong, Anicetus Suireng, Abdel Jelil Njouendou, Joseph D. Turner, Laura Dean, Mark J. Taylor, Ernestine Ebot Ashu, Theobald Mue Nji, Louise Hamill, Emmanuel Kah
Publikováno v:
SSRN Electronic Journal.
Background: Onchocerciasis is targeted for elimination with annual community-directed treatment with ivermectin (CDTi). High infection levels were reported in South-West Cameroon, despite ≥ 15 years of CDTi. Methods: A large-scale cross-sectional s
Autor:
Ebua Gallus Fung, Kim Ozano, Michele E. Murdoch, Samuel Wanji, Desmond Akumtoh Nkimbeng, Maame Esi Woode, Winston Patrick Chounna Ndongmo, Elisabeth Dibando Obie, Louis W. Niessen, Helen Piotrowski, Victoria Watson, Louise Hamill, Emmanuel Kah, Armelle Forrer, Rachael Thomson, Samuel Teghen, Joseph D. Turner, Zakariaou Njoumemi, Raphael A. Abong, Mark J. Taylor, Peter Enyong, Abdel Jelil Njouendou, Sally Theobald, Jahangir A. M. Khan, Dum Buo Nnamdi, Andrew Amuam, Bertrand L. Ndzeshang, Relindis Ekanya, Laura Dean, Theobald Mue Nji
Publikováno v:
Parasites & Vectors
PARASITES & VECTORS
Parasites & Vectors, Vol 12, Iss 1, Pp 1-13 (2019)
PARASITES & VECTORS
Parasites & Vectors, Vol 12, Iss 1, Pp 1-13 (2019)
BackgroundOnchocerciasis is a priority neglected tropical disease targeted for elimination by 2025. The standard strategy to combat onchocerciasis is annual Community-Directed Treatment with ivermectin (CDTi). Yet, high prevalence rates and transmiss
Autor:
Peter Enyong, Bertrand L. Ndzeshang, Samuel Wanji, Desmond Akumtoh Nkimbeng, Winston Patrick Chounna Ndongmo, Elisabeth Dibando Obie, Mathias Esum Eyong, Ebua Gallus Fung, Samuel Teghen, Raphael A. Abong, Relindis Ekanya, Armelle Forrer, Amuam Andrew Beng, Joseph D. Turner, Laura Dean, Abdel Jelil Njouendou, Dum-Buo Nnamdi, Mark J. Taylor, Anicetus Suireng, Louise Hamill, Ernerstine Ebot Ashu, Sally Theobald, Emmanuel Kah, Helen Piotrowski, Rachael Thomson, Theobald Mue Nji, Michele Me Murdoch, Kim Ozano
Publikováno v:
BMJ Global Health, Vol 6, Iss 1 (2021)
BMJ Global Health
BMJ Global Health
IntroductionOnchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to